Analyzing Provisional Rights for Patent Applicants
With the passage of the Domestic Publication of Foreign Filed Patent Applications Act of 1999, the U.S. Congress instituted a pre-grant patent publication system. As a result, the USPTO must now publish domestic utility patent applications filed on or after November 29, 2000 within 18 months of their earliest priority date, unless conditions for preventing publication are met.
Jumping Through Hoops: Discovery of Records under HIPAA
When medical malpractice defense counsel first heard of the new privacy regulations issued by the U.S. Department of Health and Human Services under the Health Insurance Portability and Accountability Act of 1996 (the HIPAA privacy regulations), most probably thought that these detailed and complicated laws would affect only their regulatory health care colleagues. How great an impact the HIPAA privacy regulations will have on medical malpractice litigation, in general, is yet to be seen, but it is clear that these regulations have immediately affected discovery of medical records in med-mal cases.
So Far So Good for the Legal Industry
It's been a dramatic year so far for the legal industry, with signs of improvement evident, according to Hildebrandt International's mid-year report. The company provided a summary of the report for <i>Law Firm Partnership & Benefits</i>.
Is Your Process Patent Being Circumvented? Housey Forces Another Look at Section 271 Protections for Information-Producing Patented Processes
Patents containing process claims, especially those where the result of the process is information, such as some research method, business method or software, Internet or telephone-based process patents, may be among the most valuable elements of a portfolio. If used defensively, such patents may provide a competitive advantage to the owner or prevent competitors from entering into a key line of business. If used offensively, these patents offer licensing opportunities on transactions that may occur millions of times per year. Potential licensees that wish to practice the patented processes described above, however, may choose a course other than licensing — practicing the process abroad and sending the resulting information back into the United States. The recent case of <i>Bayer AG v. Housey Pharmaceuticals, Inc.,</i> No. 02-1598, slip op. (Fed. Cir. Aug. 22, 2003), construing 35 U.S.C. '271(g), may make it more difficult to enforce these process patents with respect to such outsourcing and importing activities.
The FDA's Role in Product Liability Litigation
Aside from promulgating regulations, imposing rigorous standards on myriad product manufacturers, and conducting research and studies on all such products, the FDA also takes an active role in participating in an array of product liability litigations both on the state and federal levels. Often, the FDA's position and "expertise" on an issue carry great weight with the courts and consequently can affect the outcome of litigation. Thus, defense counsel involved in product liability matters in which the FDA historically has had an interest should keep abreast of the FDA's positions on the relevant issues.
Case Briefs
Highlights of the latest insurance cases from around the country.
Case Notes
Highlights of the latest product liability cases from around the country.
Online
If you require information about toxic chemicals, visit the National Toxicology Program (NTP) at <i>http://ntp-server.niehs.nih.gov.</i> The NTP was established in 1978 by the Department of Health and Human Services (DHHS) to coordinate toxicological testing programs within the department; strengthen the science base in toxicology; develop and validate improved testing methods; and provide information about potentially toxic chemicals to health regulatory and research agencies, the scientific and medical communities, and the public.
Fear Factor: Supreme Court Permits Mental Anguish Damages for Fear of Cancer
The Supreme Court's March 10th ruling in <i>Norfolk & Western Railway Co. v. Ayers,</i> No. 01-963, marks the Court's third recent foray into the federal tort law that is the Federal Employers' Liability Act (FELA) and provides ammunition for plaintiffs in product liability cases who are seeking to recover damages for mental anguish. In <i>Ayers,</i> the Court, by a 5-4 majority, held that mental anguish damages resulting from fear of cancer may be recovered under FELA by a railroad worker suffering from asbestosis caused by asbestos workplace exposure.